'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial
Interval breast cancer is one that appears between two reviews of a screening program. That is, it is diagnosed after a test whose result was negative and before the next evaluation. For obvious reasons, it is a very reliable ...
Mar 19, 2024
0
0